Sep 3, 2025 08:05AM

Aug 14, 2025 07:19AM

Mar 11, 2025 08:05AM

Feb 5, 2025 08:05AM

Jan 7, 2019 08:30AM

Jan 3, 2019 08:30AM

Dec 11, 2018 08:32AM Cellectar Biosciences (CLRB) Secures Patent in Japan for CLR 131

Dec 11, 2018 08:30AM

Dec 4, 2018 08:30AM

Nov 13, 2018 08:30AM

Nov 12, 2018 08:30AM

Oct 2, 2018 08:04AM

Oct 2, 2018 08:00AM

Sep 25, 2018 08:39AM Cellectar Biosciences (CLRB) CLR 131 Granted DA Orphan Drug Designation for Treatment of Pediatric Osteosarcoma

Sep 25, 2018 08:30AM

Sep 24, 2018 08:00AM

Sep 17, 2018 08:34AM

Sep 17, 2018 08:30AM

Aug 20, 2018 08:30AM

Aug 13, 2018 08:00AM

Aug 10, 2018 08:00AM Cellectar Reports 2018 Second Quarter Financial Results and Provides Business Update

Aug 1, 2018 08:30AM

Jul 31, 2018 04:05PM

Jul 27, 2018 08:30AM

Jul 18, 2018 08:00AM

Jul 17, 2018 08:00AM

Jul 13, 2018 04:05PM

Jul 9, 2018 08:08AM Cellectar Biosciences (CLRB) CLR 131 Receives FDA Orphan Drug Designation for Treatment of Ewing's Sarcoma

Jul 9, 2018 08:00AM

Jun 28, 2018 08:00AM

Jun 7, 2018 08:33AM

Jun 7, 2018 08:30AM

Jun 6, 2018 08:02AM

Jun 6, 2018 08:00AM

May 11, 2018 08:00AM Cellectar Reports Recent Corporate Highlights and 2018 First Quarter Financial Results

May 9, 2018 02:29PM

May 9, 2018 02:28PM

May 2, 2018 08:10AM

May 2, 2018 08:00AM

Apr 17, 2018 08:02AM

Apr 17, 2018 08:00AM

Apr 16, 2018 08:05AM Cellectar Presents Preclinical Data at AACR Annual Meeting Demonstrating the Ability of its PDCs to Selectively Target a Broad Range of Tumor Cells

Apr 16, 2018 08:02AM

Apr 16, 2018 08:00AM

Apr 4, 2018 08:01AM

Apr 4, 2018 08:00AM

Apr 3, 2018 08:02AM

Apr 3, 2018 08:00AM

Mar 27, 2018 08:00AM Cellectar Granted Seminal U.S. Patent for Phospholipid-Ether Analogs as Cancer-Targeting Drug Vehicles

Mar 21, 2018 04:10PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All